OTHER INFECTIOUS DISEASES — Percent Change (as a percent)
Johnson & Johnson OTHER INFECTIOUS DISEASES — Percent Change (as a percent) increased by 40.6% to -10.4% in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 78.2%, from -47.6% to -10.4%. Over 2 years (FY 2021 to FY 2024), OTHER INFECTIOUS DISEASES — Percent Change (as a percent) shows a downward trend with a 195.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Positive growth signals strong market adoption or successful lifecycle management, whereas negative growth suggests market saturation, loss of exclusivity, or competitive displacement.
Detailed definition
This metric measures the period-over-period percentage growth or decline in net sales for the Other Infectious Diseases...
Peer comparison
Comparable to organic revenue growth rates reported by pharmaceutical peers for specific therapeutic sub-segments or niche product portfolios.
jnj_segment_other_infectious_diseases_percent_change_as_a_percentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -13% | 7.8% | -6.5% | -15.3% | -5.4% | -22.4% | -9.8% | -5.2% | -3.6% | -0.3% | -35.1% | -23.1% | -25.4% | -13% | -47.6% | -79.8% | -17.5% | -10.4% |
| QoQ Change | — | +160.0% | -183.3% | -135.4% | +64.7% | -314.8% | +56.3% | +46.9% | +30.8% | +91.7% | <-999% | +34.2% | -10.0% | +48.8% | -266.2% | -67.6% | +78.1% | +40.6% |
| YoY Change | — | — | — | — | +58.5% | -387.2% | +35.9% | +3.7% | +83.9% | — | -258.2% | -344.2% | -605.6% | <-999% | -35.6% | -245.5% | +31.1% | +78.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's other infectious diseases — percent change (as a percent)?
- Johnson & Johnson (JNJ) reported other infectious diseases — percent change (as a percent) of -10.4% in Q1 2026.
- How has Johnson & Johnson's other infectious diseases — percent change (as a percent) changed year-over-year?
- Johnson & Johnson's other infectious diseases — percent change (as a percent) increased by 78.2% year-over-year, from -47.6% to -10.4%.
- What is the long-term trend for Johnson & Johnson's other infectious diseases — percent change (as a percent)?
- Over 2 years (2021 to 2024), Johnson & Johnson's other infectious diseases — percent change (as a percent) has grown at a 195.0% compound annual growth rate (CAGR), from -11.1% to -96.6%.
- What does other infectious diseases — percent change (as a percent) mean?
- The percentage growth rate of sales for the Other Infectious Diseases product line compared to the previous period.